# COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction

> **NCT02987387** · — · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 57 (actual)

## Conditions studied

- Pulmonary Valve Insufficiency
- Pulmonary Valve Stenosis
- Heart Defects, Congenital
- Congenital Abnormalities
- Cardiovascular Diseases
- Heart Diseases

## Interventions

- **DEVICE:** SAPIEN XT THV

## Key facts

- **NCT ID:** NCT02987387
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-17
- **Primary completion:** 2021-08-09
- **Final completion:** 2025-09-30
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987387, "COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02987387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*